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ABSTRACT
Determination of copy number variants (CNVs)
inferred in genome wide single nucleotide
polymorphism arrays has shown increasing utility
in genetic variant disease associations. Several
CNV detection methods are available, but differ-
ences in CNV call thresholds and characteristics
exist. We evaluated the relative performance of
seven methods: circular binary segmentation,
CNVFinder, cnvPartition, gain and loss of DNA,
Nexus algorithms, PennCNV and QuantiSNP.
Tested data included real and simulated Illumina
HumHap 550 data from the Singapore cohort study
of the risk factors for Myopia (SCORM) and
simulated data from Affymetrix 6.0 and platform-
independent distributions. The normalized singleton
ratio (NSR) is proposed as a metric for parameter
optimization before enacting full analysis. We used
10 SCORM samples for optimizing parameter
settings for each method and then evaluated
method performance at optimal parameters using
100 SCORM samples. The statistical power, false
positive rates, and receiver operating characteristic
(ROC) curve residuals were evaluated by simulation
studies. Optimal parameters, as determined by NSR
and ROC curve residuals, were consistent across
datasets. QuantiSNP outperformed other methods
based on ROC curve residuals over most datasets.
Nexus Rank and SNPRank have low specificity and
high power. Nexus Rank calls oversized CNVs.
PennCNV detects one of the fewest numbers of
CNVs.
INTRODUCTION
Copy number variants (CNVs) are duplications, insertions
or deletions of chromosomal segments that are 1 kb
(1,2). Multiple experimental techniques can detect
CNVs, including bacterial artificial chromosome (BAC)
arrays, paired end mapping, fluorescent in situ hybridiza-
tion, representational oligonucleotide microarray analysis
(ROMA) and whole genome single nucleotide poly-
morphism (SNP) arrays (3). Due to increased use of
genome wide association (GWA) studies, SNP arrays
with sufficiently high-density (>300K SNPs) have
become a convenient tool for studying CNVs. Accurate
CNV detection in SNP arrays requires sophisticated
algorithms or statistical methods. The accuracy of
CNV boundaries derived from SNP arrays is influ-
enced by multiple factors such as the robustness of the
statistical method, batch effects, population stratification
and differences between experiments (4; http://www.
goldenhelix.com/Downloads/login.html?product=SVS&
view=./Events/recordings/wgacnv2008/wgacnv2008.html).
Experimental validation is therefore important to confirm
the accuracy of CNVs derived from SNP array platforms.
To date, several detection methods are available for
identifying CNVs from genome-wide SNP array data.
Most were initially developed for array comparative
genomic hybridization (aCGH) platforms. The statistical
models underlying these approaches include hidden
Markov models (HMMs) (5,6), segmentation algorithms
(7,8), t-tests and standard deviations (SDs) of the logR
ratio (9). While these free or commercial programs are
available for detecting CNVs from SNP arrays, a
thorough comparison of these methods, particularly, the
recently developed ones, has not been conducted. The
most recent comprehensive survey of the performance of
CNV detection methods was performed in 2005, in which
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Lai et al. (10) tested 11 methods using receiver operating
characteristic (ROC) curves and found that segmentation
algorithms performed consistently well. However, a few
nonsegmentation methods proposed recently such as the
QuantiSNP (5) and PennCNV (6) programs were not
included. Furthermore, although utilization of high-
density SNP arrays to infer CNVs is increasing, the appli-
cation of these methods on real data is in its infancy.
Many practical considerations need further exploration,
such as the determination of optimal parameters for
each method, parameter setting impact on CNV detection
and CNV size, and method adjustments with various CNV
sizes, signal levels and signal variations.
In this study, we compared seven frequently used CNV
detection methods: circular binary segmentation (CBS)
(8), CNVFinder (9), cnvPartition, gain and loss of DNA
(GLAD) (7), Nexus segmentation methods Rank and
SNPRank, PennCNV (6) and QuantiSNP (5) for the fol-
lowing aspects: (i) optimal parameter settings for each
method; (ii) sensitivity, specificity, power and false
positive rates of each calling algorithm and (iii) conditions
where a method failed to call correct boundaries and
where a method detected different CNV sizes.
MATERIALS AND METHODS
Datasets
We used both genome wide SNP arrays and simulated
data (described later) to evaluate the performance of
these CNV detection methods. The SNP array data were
obtained from the GWA study of the Singapore cohort
study of the risk factors for Myopia (SCORM). SCORM
is a longitudinal cohort designed to evaluate the environ-
mental and genetic risk factors for myopia in Singapore
Chinese schoolchildren. A total of 1979 school children
from Grades 1–3 in Singapore were followed up yearly
by ophthalmologists and optometrists, who measured
refractive error, keratometry, axial length, anterior
chamber depth, lens thickness and vitreous chamber
depth. Buccal samples were collected from 1875 children
(aged 8–12 years), in which 1116 samples from Chinese
participants were genotyped using Illumina HumanHap
550 and 550 Duo BeadArrays. The study protocol was
approved by the Institutional Review Boards of the
National University of Singapore and the Singapore Eye
Research Institute.
In this study, we analyzed the following three subsets of
SNP arrays from the SCORM GWA study: (i) a training
dataset of 10 unrelated control samples (five males and
five females) from the 550 nonduo chips who had no
myopia or hyperopia (emmetropic, spherical equivalent
between 0.50 and +0.50 diopters in both eyes) and
had the highest genotyping quality (call rate 0.98); (ii)
a pilot dataset of 16 SNP arrays generated from different
sources of DNA specimens from five individuals, all with
buccal, whole genome amplified buccal and saliva-derived
DNA samples, in which one individual also had an array
genotyped from the blood-derived DNA sample; (iii) an
analysis dataset of 100 unrelated emmetropic control
samples independent from the training dataset that had
high-genotyping quality (call rate  98%), SD of the
logR ratio distribution <0.3 and high correlation with
at least 95% of the total analysis samples (Pearson corre-
lation coefficient >0.75). Throughout this work, SNPs
located within the CNV boundaries detected by each
detection method are referred as CNV SNPs.
We used the training dataset to standardize parameter
settings for each method. To confirm the optimal param-
eters chosen by the normalized singleton ratio (NSR)
described below, two additional 10 sample datasets were
constructed from emmetropic individuals: one chosen
from 550 duo chips with the same criteria as the training
dataset above and one chosen from samples of moderate
genotyping quality (rank 51–60 of 112) regardless of
gender or chip type. The optimal parameter setting
derived from the training dataset was applied to both
the pilot and analysis datasets. The pilot dataset was
used to compare the performance of each CNV detection
method using different DNA sources. The analysis dataset
was used to draw conclusions for the performance of each
method. The outcomes from the SCORM CNV data were
then evaluated in a simulated dataset.
CNV detection methods
The underlying statistical models for the seven CNV
detection methods evaluated in this study differ by
varying degrees. The primary raw data used for detecting
CNVs from SNP arrays are the SNP intensity measured
by logR ratios. Some methods also used B allele
frequencies to enhance detection. CBS (8), Nexus 4.1
Rank and Nexus 4.1 SNPRank (http://www
.biodiscovery.com) use the same segmentation algorithm
that recursively divides chromosomes into segments of
common intensity distribution functions, but CBS has
no inherent method of determining segment significance
while Nexus uses an unknown equation to compute
segment significance (Dr Soheil Shams, CSO of
Biodiscovery, Developer of Nexus, personal communica-
tion). GLAD uses a version of adaptive weights
smoothing to build segments by adding neighboring
SNPs to the existing set of SNPs in the segment. The
QuantiSNP (5) and PennCNV (6) programs use different
HMMs. The PennCNV program uses the combined logR
ratio and B allele frequency, while the QuantiSNP
program treats them independently. The PennCNV
program generates a hidden state for copy neutral loss
of heterozygosity (LOH) and uses each population-based
B allele frequency of the SNP to infer CNVs, while the
QuantiSNP program uses a fixed rate of heterozygosity
for each SNP. The CNVFinder (9) program uses experi-
mental variability, termed SDe, in the logR ratio distribu-
tion. The cnvPartition program implemented in the
Illumina BeadStudio software uses an undocumented
method of CNV detection.
The experimental platforms for which the CNV detec-
tion methods were developed also differ. Several methods
were developed for CGH of various types: CBS for BACs
and ROMA, GLAD for BACs, PennCNV and Nexus for
Agilent and Nimblegen platforms and CNVFinder for
whole genome tile path. Nexus and PennCNV were also
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developed for Illumina and Affymetrix SNP arrays.
CNVFinder was also developed for Affymetrix SNP
arrays. cnvPartition and QuantiSNP were developed for
Illumina SNP arrays.
Optimization of method parameters
We propose using the NSR as a summary metric for
determining the optimal parameter setting for each
method. The NSR is defined as
NSR ¼ pu
cs
where pu is the proportion of unique CNV SNPs (i.e. the
proportion of the number of CNV SNPs found in only
one sample of the dataset), and mCS is the average number
of CNV SNPs called per sample. The NSR hypothesizes
that CNV SNPs called in only one sample are more likely
to be false positives than CNV SNPs that are called in
multiple samples, thus the smaller the NSR, the better
the method. Since types of parameters vary among CNV
detection methods, the parameters adjusted in this
optimization study included the following: SD for CBS,
SDe for CNVFinder, confidence for cnvPartition,
smoothed segment logR ratio for GLAD, segment thresh-
old for Nexus, confidence and CNV length in SNPs for
PennCNV and log Bayes Ratio and CNV length in SNPs
for QuantiSNP.
Comparative statistics
The SNP intensity data (logR ratios) were obtained from
the Illumina BeadStudio 3.1 program. To compare the
characteristics and quality of these CNV detection
methods, we used three reference datasets from public
databases: CNVs from SNP studies in the Database
of Genomic Variants (DGV; http://projects.tcag.ca/
variation) (3) (7950 CNVs; 99 645 CNV SNPs); the set
of HapMap CNVs in Asian populations reported by
Redon et al. (11) (5753 CNVs; 25 799 CNV SNPs) and
the subset of all experimentally confirmed CNVs from
Redon et al. (11) (275 CNVs; 4984 CNV SNPs).
For each CNV detection method, the CNV results for
the tested dataset (e.g. SCORM dataset) were compared
to the reference dataset for each sample. Assuming that all
CNVs in the reference datasets are true, the sensitivity,
specificity and kappa statistics were computed from the
CNV results for all datasets. Since some CNV detection
methods such as Nexus cannot correctly handle CNVs in
chromosomes X or Y, these chromosomes and the
mitochondrial genome were excluded from the analyses.
Accounting for CNV SNPs and CNVs detected in
multiple methods
The performance of the seven CNV detection methods
was evaluated at both SNP and CNV levels. The CBS,
cnvPartition, Nexus Rank and SNPRank, PennCNV
and QuantiSNP programs produced CNV boundaries
directly, providing the start and end base pair map loca-
tions for the CNV detected. The CNVFinder and GLAD
programs directly designated the gain or loss of informa-
tion of each CNV SNP rather than indicating CNV
boundaries. For these latter two methods, we defined a
CNV as three or more consecutive CNV SNP calls and
excluded regions with one or two CNV SNP calls from the
analysis.
Correlation between chips
We computed pair-wise Pearson correlations among a set
of 20 samples, in which 10 samples were randomly chosen
from each BeadArray platform to evaluate sample quality
and effects caused by differences between the HumanHap
500 and 500 Duo arrays (Supplementary Table S1).
Pearson correlation tests were also conducted on all
emmetropic individuals in the SCORM dataset, and
samples with pair-wise correlation values <0.75 with
more than five other samples were excluded in the three
SCORM subsets presented here.
Receiver operating characteristic curve residuals
Methods at optimal parameters were compared by using
both ROC curves and ROC curve residuals, the distances
from a point on the ROC curve to the diagonal line of
y= x for each method. The residuals are calculated using
the equation:
ffiffiffi
2
p ðsensitivity ð1 specificityÞÞ
2
:
The largest ROC curve residuals are optimal.
Simulated datasets
Simulated CNV data were generated to compare the
power, false positive rates and boundary calling properties
of the CNV detection methods. cnvPartition data were
unable to be simulated because of the limitations of data
input into BeadStudio. We compared the parameter
settings based on the optimal ROC curve residual and
on the optimal NSR. Exactly matched boundary calling
refers to the CNV region reported by the detection method
having the same starting and ending SNPs as the one
predesignated in the simulation.
For the simulations mimicking Illumina arrays, we
directly used the logR ratio data in the SCORM sample
to generate the logR ratio of non-CNV SNPs rather than
generating from a given distribution. Among samples in
the training and analysis datasets, we chose one sample
with mean logR ratio of 0.01 and SD of 0.15, which is
the average logR ratio and SD of total samples of these
two datasets. We randomly sampled a logR ratio from
this sample to assign to the non-CNV SNPs in the
simulated datasets.
Two sets of Illumina simulations were conducted to
generate the logR ratio of the CNV SNP. In simulation
1, we assigned CNVs to the positions shown in Figure 1,
mimicking chromosome 1. The CNV at each position was
assigned a specific copy number (0, 1, 3 or 4) and size (10,
20 or 30 SNPs). The logR ratio of each CNV SNP was
equal to a random number drawn within the interval
designated for each CNV: 2±SD for 0 copy CNVs,
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1±SD for one copy CNVs, 0.585±SD for three copy
CNVs and 1±SD for four copy CNVs, where we
prespecified both copy number, SD (0.1–0.3 of the base
logR ratio) and the length (number of SNPs) at each CNV
location (Figure 1).
In simulation 2, CNVs were designed to reflect CNVs
detected in the SCORM samples, from those detected by
all seven methods (highest number of replicated CNVs) to
those detected by three methods (moderate number of
replicated CNVs). First, all CNVs to be simulated were
spaced every 1000 SNPs apart as shown in Figure 1. We
then designated the copy number of the CNV (sim2 copy:
0, 1, 3 or 4), the frequency of the detection methods that
detected the same CNV (sim2 mm: 3–7) and CNV length
in SNPs (sim2 size: 3–17) at each CNV location (Figure 1).
Second, we created a pool of CNVs from the analysis
dataset of SCORM, which were detected by three to
seven of the methods tested herein and computed the
mean and SD of each CNV. Finally, at each CNV
location, we randomly chose a CNV from the pool that
had the same copy number, frequency of the detection
methods and CNV size as designated in Figure 1. At
each CNV location, we simulated the same numbers of
CNV SNPs with logR ratio of each SNP randomly
drawn from the interval of mean ± SD. For each simu-
lation, 100 replicates were generated.
A neutral simulation was designed as a platform inde-
pendent test of CNV detection methods. LogR ratios of
all SNPs were initially assigned by drawing from a normal
distribution with mean 0 and SD 0.25, which is between
the Illumina and Affymetrix SDs of datasets used in this
study. Forty-eight CNVs, 12 for each of copy numbers 0,
1, 3 and 4 were created by replacing initial logR ratios
with logR ratios from the CNV distribution as detailed in
Supplementary Table S2. CNVs were placed every 1000
SNPs. For each sample, each CNV was given a random
size of 3–15 SNPs and was randomly placed at one of 48
locations. B allele frequencies were randomly assigned
from a range of 0–0.07 for AA, 0.52–0.68 for AB and
0.89–1 for BB, where all genotypes are equally likely.
SNP positions were spaced randomly from 1–10 000 bp.
Since QuantiSNP and PennCNV calls are dependent on
platform data, SNP names from Illumina HumanHap 550
chromosomes 18–22 were used.
A simulation based on Affymetrix 6.0 chip data was
designed using logR ratio and B allele frequency data
generated by PennCNV-Affymetrix (6) from Gene
Expression Omnibus (GEO) (12) dataset GSE13372 (13).
LogR ratios of all SNPs were initially assigned by drawing
from a normal distribution with mean and SD equal to the
mean of these two statistics in the GSE13372 samples.
Forty CNVs, 10 for each of copy numbers 0, 1, 3 and 4
Table 1. Results of NSR optimization search on the training datasets
Method Parameters CNV SNPs
per Sample
Unique CNV
SNPs
NSR ROC
residual
CBS 1 standard deviation 275 0.8050 0.00293 0.00284
3 standard deviations 270 0.8135 0.00302 0.00325
4 standard deviations 265 0.8169 0.00309 0.00316
5 standard deviations 130 0.9158 0.00707 0.00079
CNVFinder SDe=6, 4, 4, 2 630 0.8476 0.00135 0.0016
SDe=7, 5, 4, 2 446 0.8907 0.00200 0.00114
SDe=8, 7, 6, 5 258 0.9037 0.00350 0.00061
cnvPartition Confidence >0 195 0.8187 0.00420 0.00257
Confidence >5 193 0.8185 0.00425 0.00253
Confidence >10 186 0.8167 0.00440 0.00249
GLAD Default 262 0.7245 0.00276 0.00208
Segment logR > |0.3| 243 0.7476 0.00307 0.00186
Segment logR > |0.4| 192 0.7724 0.00402 0.00111
Nexus Rank Threshold <0.01 10 126 0.8696 8.588E–5 0.00481
Threshold <0.001 2041 0.9385 0.00046 0.00349
Threshold <0.0001 540 0.9137 0.00169 0.00312
Nexus SNPRank Threshold <0.01 235 0.7862 0.00335 0.00288
Threshold <0.001 206 0.7816 0.00380 0.00272
Threshold <0.0001 185 0.7889 0.00426 0.00246
PennCNV All CNV calls 271 0.7909 0.00292 0.00284
SNPs >1 248 0.7677 0.00310 0.00282
QuantiSNP L=2000000 332 0.8793 0.00265 0.00313
L=3000000 314 0.8423 0.00268 0.00311
L=4000000 283 0.7978 0.00282 0.00308
Log Bayes 0 311 0.8312 0.00267 0.00308
Log Bayes 2.5 268 0.8111 0.00303 0.00299
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Table 2. Number of CNV SNPs and ROC curve residuals for each DNA type in the pilot dataset
Method Parametera Measureb Buccal Saliva Blood Amplified Buccal
CBS 1 SD CNV SNPs 391 209 688 51 404
ROC residual 0.0024 0.0009 8.3E–5 0.0217
4 SD ROC residual 0.0024 0.0009 5.9E–5 0.0217
CNVFinder 6,4,4,2 SDe CNV SNPs 336 371 218 2032
ROC residual 0.0007 0.0007 0.0008 0.0063
7,5,4,2 SDe ROC residual 0.0005 0.0005 0.0007 0.0038
cnvPartition Confidence >0 CNV SNPs 329 212 410 4900
ROC residual 0.0018 0.0012 0.0013 0.0166
Confidence >5 ROC residual 0.0018 0.0012 0.0013 0.0167
GLAD All calls CNV SNPs 135 157 646 7667
ROC residual 0.0011 0.0010 0.0009 0.0121
Smoothed m > |0.3| ROC residual 0.0011 0.0010 0.0011 0.0122
Nexus Rank Threshold=1E–2 CNV SNPs 29 843 54 662 57 186 285 812
ROC residual 0.0057 0.0098 0.0573 0.0096
Threshold=1E–4 ROC residual 0.0026 0.0029 0.0014 0.0170
Nexus SNPRank Threshold=1E–2 CNV SNPs 592 1528 2717 85 646
ROC residual 0.0016 0.0008 0.0003 0.0217
Threshold=1E–4 ROC residual 0.0011 0.0008 0.0003 0.0216
PennCNV SNPs 1 CNV SNPs 278 411 382 6 663
ROC residual 0.0016 0.0016 0.002 0.0201
SNPs 2 ROC residual 0.0016 0.0016 0.0019 0.0142
Confidence >2 ROC residual 0.0016 0.0016 0.0019 0.0144
QuantiSNP L=2M CNV SNPs 468 739 568 36 200
ROC residual 0.0026 0.0022 0.0029 0.0267
L=2M; LBF >0 ROC residual 0.0025 0.0021 0.0023 0.0235
aBold text designates NSR optimal parameter results for each method.
bCNV SNPs are given as number per sample.
Figure 1. Positions of simulated copy number variants with University of California Santa Clara genome browser (http://genome.ucsc
.edu/cgi-bin/hgGateway) tracks on chromosome 1. The copy number (sim1 copy, sim2 copy), the size of copy number variant (sim1 size, sim2
size) and the frequency of copy number variant detection method (sim2 mm) were designated at each location for simulations 1 and 2.
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were created. First, a CNV detected by PennCNV within
the GSE13372 dataset was randomly selected. Second,
logR ratios were generated by drawing from a normal
distribution with the mean and SD of the randomly
selected CNV from the GEO dataset (Supplementary
Table S3). CNV position and size and B allele frequency
were assigned as in the neutral simulation. CNVs were
placed every 1000 SNPs. SNP positions were spaced
randomly from 1 to 5000 bp to model Affymetrix 6.0
chip density. Since QuantiSNP only works on Illumina
data, chromosome 1 SNP names from Illumina
HumanHap 550 were used for QuantiSNP, the
PennCNV Illumina HMM and Nexus Rank and SNP
Rank. Affymetrix SNP names were tested on the
PennCNV gw6 and agre HMMs.
RESULTS
Optimization of method parameters
The minimum NSR was observed for parameter settings
of 1 SD for the CBS program, (6, 5, 4 and 2 SDe) for the
CNVFinder program, 0 confidence for the cnvPartition
program, a=0.001 for the GLAD program, 1 SNP
length for the PennCNV program, significance threshold
=0.01 for the Nexus Rank and Nexus SNPRank
programs and L=2000 000 for the QuantiSNP
programs using the training dataset (Table 1). These
optimal parameters also lead to maximum ROC curve
residuals for all but CBS. ROC residuals were calculated
using our Asian HapMap CNV database. The same
parameter settings were also observed as optimal for the
analysis dataset and the large majority of parameter-DNA
source combinations in the pilot dataset by ROC curve
residuals (Tables 2 and 3). In simulation 1, the optimal
parameters for ROC curve residuals are typically maximal
at more conservative parameters than NSR optimal
parameters, because NSR optimized parameters decreased
specificity without increasing sensitivity (Supplementary
Table S4). In all other simulations, sensitivity continued
to increase more quickly than 1-specificity, and so optimal
parameters concluded by NSR and ROC curve residuals
agree with those concluded for the training dataset except
for Nexus Rank (Supplementary Table S4). Overall,
almost all datasets confirm the validity of the NSR as a
metric in choosing optimal parameters.
The number of CNV SNPs detected at optimal param-
eters was typically 150–350 per sample, with cnvPartition
calling the fewest. Nexus Rank, however, called by far the
most CNV SNPs per sample, over 10 000. Even so, it also
had the best ROC residual of all methods (Table 1).
QuantiSNP had double the number of CNV SNPs of
most methods and also had good NSR and ROC statis-
tics. GLAD had the lowest proportion of unique CNV
SNPs (0.72), and QuantiSNP had the highest proportions
(0.88). Optimal NSR parameters were identical for all
methods over three training datasets varying in chip type
and genotype rate.
Method performance for multiple DNA sources
Table 2 summarizes the average number of CNV SNPs per
sample and ROC curve residuals for each method at NSR
Table 3. ROC curve residuals used to optimize parameters on the analysis dataset
Method Parameter DGV
ROC residual
HapMap Asian
ROC residual
HapMap confirmed
ROC residual
CBS 5 SD 4.41E–4 6.91E–4 0.0020
3 SD 4.99E–4 8.22E–4 0.0023
1 SD 9.62E–4 0.00172 0.0035
CNVFinder 8,7,6,5 SDe 1.85E–4 2.56E–4 8.36E–4
7,5,4,2 SDe 3.76E–4 5.10E–4 0.0015
6,4,4,2 SDe 6.46E–4 9.03E–4 0.0024
cnvPartition Confidence >10 6.98E–4 0.00146 0.0026
Confidence >5 7.21E–4 0.00148 0.0027
Confidence >0 7.33E–4 0.00153 0.0028
GLAD Smoothed m >|0.4| 5.04E–4 7.99E–4 0.0022
Smoothed m >|0.3| 5.87E–4 9.59E–4 0.0024
Default 6.78E–4 0.00107 0.0026
Nexus Rank Threshold 1E–4 0.00313 0.00307 0.00293
Threshold 1E–3 0.00432 0.00386 0.00816
Threshold 1E–2 0.00744 0.00578 0.03105
Nexus SNPRank Threshold 1E–4 8.95E–4 0.00128 1.23E–4
Threshold 1E–3 0.00106 0.00147 1.69E–4
Threshold 1E–2 0.00122 0.00174 1.79E–4
PennCNV Confidence >17.5 7.35E–4 0.00131 0.0025
Confidence >10 9.01E–4 0.00155 0.0030
SNPs 1 9.65E–4 0.00166 0.0032
QuantiSNP Log Bayes >10 9.23E–4 0.00159 0.0030
Log Bayes >2.5 0.0012 0.00196 0.0038
L=2E6 0.0015 0.00228 0.0043
Maximal ROC curve residuals are optimal and indicated in bold.
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optimal and suboptimal parameters for four DNA types
in the pilot dataset. As with the training dataset, the
Nexus algorithms overcalled CNV SNPs with as many
as three (SNPRank) to 100 (Rank) times the number of
calls of other methods (Table 2). The number of SNPs of
the Nexus CNVs in the saliva data was small compared to
the size of other methods’ CNVs, especially GLAD and
cnvPartition, which were more than double the size of the
Nexus CNVs. The pattern across DNA types was similar
between Nexus and other methods. Amplified buccal
DNA consistently showed the highest number of CNV
SNPs (2032–225 597) across all methods in comparison
to other DNA types (135–39 759). The excessive number
of CNV calls in amplified buccal DNA caused bias of the
ROC curve residuals, resulting in it having the best per-
formance across all methods. The relationship between the
number of CNV and CNV SNP calls in the pilot dataset is
found in Table 4. If amplified buccal DNA is disregarded
because of overcalling, the ROC residuals were best in
blood-derived DNA samples in half of the methods.
Overall, the performance of DNA from saliva, blood
and buccal swabs was comparable in terms of the
number of CNV SNP calls and the value of the ROC
curve residuals, which is consistent with the observation
of genotype call rates (data not shown).
Method performance by analysis dataset
at optimal parameters
The Nexus Rank algorithm again overcalled CNV SNPs
(31 796 per sample), and the cnvPartition program
detected the least number of CNV SNPs (185 per
sample) with at least 40% fewer calls than other
methods (Supplementary Table S5). The segmentation
methods CBS and GLAD had similar call numbers. The
HMM-based PennCNV and QuantiSNP algorithms had
divergent CNV SNP call detection numbers (average 295.6
vs. 701.9 CNV SNPs, respectively). Call numbers were
correlated to sensitivity, specificity and kappa. Given
this correlation, GLAD and CNVFinder did not
perform as well as expected for sensitivity, specificity
and kappa given their number of CNV SNP calls
(Supplementary Table S5). CNVs from GLAD and
SNPRank (21 and 22 SNPs long) were four times as big
as PennCNV (5 SNPs long) on average. Rank and CBS
CNVs were also small at an average of 6 SNPs per CNV.
Further details on the relationships between CNVs and
CNV SNPs are in Table 4.
Nexus Rank, QuantiSNP and Nexus SNPRank were
the top three programs on our DGV and HapMap
Asian CNV databases (ROC residuals 0.0058, 0.0023
and 0.0017, respectively, on the HapMap Asian
database) (Table 3, Figure 2). However, Rank falls to
the bottom rank in the HapMap Confirmed database.
The high ROC curve residuals in the Nexus algorithms
were primarily due to overcalling CNVs, which results in
sensitivity increasing more quickly than 1-specificity
(Table 3). Nexus Rank and CNVFinder had wide distri-
butions of residuals, demonstrating a lot of sample-
to-sample variation. The SD of Rank’s sensitivity and
specificity distributions were approximately equivalent
(0.045 and 0.04, respectively), indicating that the
primary factor in the variance is the number of CNV
calls per sample. When the total number of CNV calls
was fixed to the same level for these methods, we
observed smaller ROC curve residuals for the Nexus
programs than that of the QuantiSNP and CBS
programs (data not shown).
Method performance by simulation 1 at optimal
parameters
Ranking by ROC curve residual. Parameters other than
those displayed in Supplementary Tables S4 and S6 were
tested. Parameters displayed reflect ROC optimal param-
eters for simulation 1, NSR optimized parameters or
parameters with measurable differences from the optimal
parameter. Methods ranked from first to last using CNVs
were as follows: QuantiSNP and Nexus SNPRank,
PennCNV (average ROC residual = 0.707), PennCNV
(0.703), CBS (0.675), GLAD (0.631), Nexus Rank (0.598)
and CNVFinder (0.061) (Figure 4c; Supplementary
Table S4). The interquartile ranges (IQRs) of the highest
ranking methods: CBS, Nexus SNPRank, PennCNV and
QuantiSNP have the highest ROC residuals and are
overlapping (Figure 3a). These methods also displayed
comparable sensitivity and specificity rates. Power and
false positive rates differed between the CNV and CNV
SNP levels, and so ROC values and rankings also
differed (Figure 4; Supplementary Table S6).
Table 4. The relationship between CNV SNPs and CNVs
CBS CNVFinder cnvPartitiona GLAD Nexus rank Nexus SNPRank PennCNV QuantiSNP
Pilot CNV SNPs 1046 1855 1060 785 273 311 7640 2055 3694
Pilot CNVs 127 210 64 62 42 468 1405 405 369
Pilot SNPs/CNV 8.24 8.83 16.56 12.66 6.44 5.44 5.07 10.01
Analysis CNV SNPs 35 650 119 780 18 520 32 300 3 179 600 43 370 29 560 70 190
Analysis CNVs 5680 13 110 1380 1520 544 410 1960 6030 29 560
Analysis SNPs/CNV 6.28 9.14 13.42 21.25 5.84 22.13 4.90 8.22
Sim 1 CNV SNPs 24 249 47 549 N/A 24 370 28 178 24 059 24 080 24 825
Sim 1 CNVs 1319 5084 N/A 1368 1448 1202 1266 1256
Sim 1 SNPs/CNV 18.38 9.35 N/A 17.81 19.46 20.02 19.02 19.77
Sim 2 CNV SNPs 21 225 21 077 N/A 19 209 23 037 20 564 21 066 23 041
Sim 2 CNVs 3587 2921 N/A 3144 2320 3346 3337 3696
Sim 2 SNPs/CNV 5.92 7.22 N/A 6.11 9.93 6.15 6.31 6.23
aN/A is used here because cnvPartition was not evaluated in the simulations.
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Figure 2. Boxplots for ROC curve residual from comparison of CNVs in the analysis dataset and three CNV databases. (a) CNVs from SNP studies
in the Database of Genomic Variants were used to compute sensitivity and 1-specificity. (b) CNVs from Asian samples in HapMap from Redon et al.
(11) were used. (c) Experimentally confirmed CNVs in all HapMap samples from Redon et al. (11) were used.
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Power and false positive rate. For this simulation, all
methods but CNVFinder showed similar power to detect
predesignated CNVs, with power greater than 99.8%
under the NSR optimal parameter setting for each
method (Figure 4a; Supplementary Table S4). False
positive CNV calls varied greatly from 0 in the
QuantiSNP and SNPRank programs to 296 in the
CNVFinder program, which translates to a range of
false positive rates from 1.65E–5 to 0.006. CNVFinder,
GLAD and Nexus Rank had high false positive rates at
both the CNV and CNV SNP levels, while CBS had a high
rate (0.08) at the CNV level alone (Figure 4b;
Supplementary Tables S4 and S6). At the CNV SNP
level, ROC residual rankings were different primarily
due to different rankings of false positive rates for the
methods. Additionally, the computation of ROC at the
CNV SNP level allowed ROC residuals to remain high
despite relatively large numbers of false positive CNV
SNPs, for example, in CNVFinder. Unlike the analysis
of SCORM SNP array data, the total number of CNVs
detected by each method displayed minimal variance in
this simulated dataset except for the CNVFinder
method, which detected the highest number of false
positive CNVs under the NSR optimal parameter setting.
Failure in CNV detection. Method performance was
impaired by simulated CNV size and copy number at
parameters that are stricter than NSR optimal. CBS did
not detect any three copy CNVs at a strict setting of 5 SD.
CNVFinder was impaired in detecting three copy CNVs at
stricter settings than optimal. PennCNV had a weakness
in detecting the simulated 10-SNP duplication CNVs but
not the simulated 20- or 30-SNP CNVs. Nexus Rank and
SNPRank had no significant failures in detection using the
attempted parameters. However, the previous version of
these algorithms (4.0) had failures in detecting the
simulated 10-SNP CNVs (data not shown). In that
version, when a stringent significance threshold of 1E–8
was applied, neither Nexus method detected 10-SNP
CNVs. The PennCNV method failed to detect 10-SNP
CNVs with copy numbers of three or four.
Figure 3. Boxplots of ROC curve residual from simulated data for each method. (a) ROC residuals from simulation 1. (b) ROC residuals from
simulation 2.
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CNV boundary calling. The average size of CNVs detected
by Nexus Rank was 3 SNPs larger than simulated, which
is consistent with the specificity and kappa statistics
observed in the real data. GLAD and CBS had the most
accurate CNV boundaries (>99 and >98%, respectively),
though CBS called a CNV with large variation as half its
simulated size 6% of the time. PennCNV and QuantiSNP
had a relatively low percentage of exact boundary calling
(80 and 60%, respectively), but the miscalled boundary
was only one SNP longer most of the time (70 and 75%,
respectively). On average, CNVFinder CNVs had half the
expected size in SNPs, while GLAD and CBS CNVs were
2 SNPs smaller than expected. Data on the relationship
between the numbers of CNV and CNV SNP calls in sim-
ulations 1 and 2 are located in Table 4.
Method performance by simulation 2 at optimal
parameters
Ranking by ROC curve residual. ROC curve residuals
were computed at both the CNV and CNV SNP levels.
By this measure at the CNV level, the top four methods in
order were as follows: QuantiSNP (0.67), CBS (0.640),
PennCNV (0.638) and Nexus SNPRank (0.606)
(Figure 4a; Supplementary Table S4). QuantiSNP, CBS,
PennCNV and SNPRank have the same ranking at the
CNV SNP level as well. For the distributions of
CNV-based ROC curve residuals, QuantiSNP’s IQR was
highest and did not overlap any other IQR. The IQRs of
CBS and PennCNV were next highest and only overlap
each other (Figure 3b). The low-ROC curve residuals for
Nexus Rank were most likely due to excessive overcalling
that resulted in low specificity (Supplementary Table S4).
QuantiSNP still ranked first based on the ROC curve
residuals derived from CNV SNPs. Overall, QuantiSNP,
CBS and PennCNV were considered to be the top three
methods from the analyses of CNVs and CNV SNPs
(Supplementary Tables S4 and S7).
Power and false positive rate. QuantiSNP, CBS and
PennCNV were also the top three methods ranked by
power and had moderate false positive rates in the
analyses of both CNVs and CNV SNPs (Figure 4a and
b; Supplementary Tables S4 and S7). These methods
demonstrated good power, ranging from 0.86 to 0.94 for
CNVs and 0.90 to 0.95 for CNV SNPs, and good false
positive rates (maximum rate=0.022 for CNVs and
2.83 104 for CNV SNPs). In contrast, at the CNV
level, Nexus Rank and SNPRank had moderate power
(e.g. 0.8 and 0.86, respectively), and Rank had a high
false positive rate (0.47). The CNVFinder program had
the lowest power for both CNV and CNV SNPs (0.75
and 0.76, respectively), but the false positive rate
was smaller than Nexus Rank (e.g. 0.003 versus 0.47).
Figure 4. Performance comparison of CNV detection methods using simulated data. (a) power, (b) false positive rate, (c) mean of ROC curve
residuals for 100 simulated samples and (d) standard deviation of ROC residuals for 100 simulated samples. CNVFinder and GLAD were not tested
on the Neutral and Affymetrix simulations and so do not appear in these graphs.
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A stricter parameter setting alleviated the high-false
positive rate of Nexus Rank, but power was also
significantly decreased.
Failure in CNV detection. Method performance was
impaired by at least one of three aspects of the simulated
CNVs: number of methods detecting the real CNV based
on the simulation (sim2 mm), copy number (sim2 copy)
and number of SNPs (sim2 size) specified in Figure 1. The
number of detection methods in the real data did not
greatly impact the performance of all methods. Only
CBS showed the trend of missing CNVs with three
copies for those modeled by three to four detection
methods, with a missing rate of >50%. The copy
number probably had the greatest impact on the perfor-
mance of each method. The GLAD program was impaired
in detecting three copy CNVs with a relatively
low-detection rate of 45%, in comparison with 91% for
detecting four copy CNVs. The CNVFinder program was
impaired in detecting three copy CNVs with a
low-detection rate of 25%, while 84% of four copy
CNVs was detected. Nexus SNPRank had a detection
rate of 72% of three copy CNVs, while 98% of four
copy CNVs was detected. Small CNV sizes were generally
harder to detect by most methods. For instance, the Nexus
Rank, PennCNV and QuantiSNP programs were
compromised detecting three to four SNP CNVs with a
wide range of detection rates: 8% for 3-SNP CNVs by
Nexus Rank, 76% for 3-SNP CNVs, 81% for 4-SNP
CNVs by PennCNV and 82% for 4-SNP CNVs by
QuantiSNP. As for impaired boundary calling, on
average, Rank CNVs were 4 SNPs longer than expected
and CNVFinder was one SNP longer.
Method performance by neutral and affymetrix
simulations at optimal parameters
These simulations were conducted to test the methods on
other SNP platforms. Methods with at least moderate
ranking in the previously discussed datasets—CBS,
Nexus Rank and SNPRank, PennCNV and
QuantiSNP—were tested. Optimal parameters for the
methods were consistent with the NSR optimized
methods in both analyses, except for Nexus Rank.
Ranking by ROC, power and false positive rates is
largely consistent with Illumina-based simulations and
real data. QuantiSNP and CBS are the top two
methods, with QuantiSNP first rank by ROC residual in
the Affymetrix simulation and CBS first rank in the
neutral simulation (Figure 4; Supplementary Table S4).
In the neutral simulation, which had CNVs with larger
variation than the other simulations (Supplementary
Table S2), QuantiSNP often had CNVs more than twice
the simulated size, because it bridged the simulated CNV
with nearby SNPs that had logR ratios that deviated from
the mean in the same direction as the simulated CNV.
PennCNV and SNPRank had low power in both
analyses, with PennCNV having much lower power than
SNPRank, which had power 4 or 15% lower than
QuantiSNP (Affymetrix and Neutral simulations, respec-
tively). Rank had the highest power, but also had the
highest false positive rate, and so it did not have the
highest ROC residual (Figure 4; Supplementary
Table S4). Of the three HMMs tested on Affymetrix sim-
ulations, PennCNV’s agre HMM had the highest ROC
residual (Supplementary Table S4).
DISCUSSION
We present a systematic evaluation of seven current
methods for detecting CNVs from genome wide SNP
chips on real Illumina data and on simulated Illumina,
Affymetrix and platform-independent data. Consistent
method performance across platforms gives evidence
that the results of this study can be extended to multiple
SNP-based platforms. While the goal was to determine an
optimal CNV detection method for real data applications,
we also present an analytical algorithm for detecting
CNVs from SNP arrays. We recommend using a subset
of samples with high-quality genotype call rates as a
training dataset to determine the best parameter setting
for a CNV detection method before analyzing the full
dataset. Our study demonstrated that the NSR can serve
as a good summary metric to determine the optimal
parameters, even for a limited sample size of 10. When
multiple detection methods were applied to the same
dataset, our study showed that ROC curve residuals,
which use sensitivity and specificity, can be a good
summary statistic to determine the performance of each
method. Through the evaluation of real SNP arrays and
simulated data, we conclude that the QuantiSNP program
outperformed other methods by the evaluation measures
(ROC curve residuals and NSR) used in this study. Two
segmentation methods, the Nexus Rank and SNPRank
programs, are ranked next to QuantiSNP. However,
deficits of these two methods were also observed as dis-
cussed below.
The top ranking performance of the QuantiSNP
program was consistent in real and simulated datasets
that were examined in this study. The fact that
QuantiSNP was designed for Illumina data may give it
an advantage in Illumina-based simulations and our real
data. However, its performance characteristics are consis-
tent in the neutral and Affymetrix simulation datasets.
Over all datasets, QuantiSNP ranked by ROC curve resid-
uall and NSR were generally higher than other methods.
The number of CNV SNP calls was average, unlike the
Nexus program, which often overcalled CNV SNPs.
Simulation studies showed that QuantiSNP had the
highest statistical power in simulation 2 to detect CNVs
(93.5%) and CNV SNPs (95.4%) (Supplementary Tables
S4 and S7). Although its false positive rate was not the
least among all methods, the rate was small (0.013 for
CNVs and 2.83 104 for CNV SNPs, simulation 2). In
other simulations, although power was not as high as
Nexus Rank, QuantiSNP had a low false positive rate
while Rank did not, and so it had a higher ROC
residual. We did not observe any major weaknesses in
CNV detection or boundary calling for the QuantiSNP
program in the Illumina or Affymetrix simulations, but
high amounts of variation in logR ratio distributions
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cause real CNVs to merge with regions of noise, creating
CNVs larger than simulated especially for simulated
CNVs of 10-15 SNPs. The Nexus Rank method also had
larger CNVs with larger variation, averaging two SNPs
larger than the model in simulation 2 and one SNP
larger than the model in simulation 1.
Both the CBS and Nexus programs are based on seg-
mentation methods and have similar rankings in terms of
performance. The CBS program had strong boundary
calling, but had trouble detecting CNVs that were
detected by the majority of CNV detection methods.
The Nexus Rank and Nexus SNPRank programs are
two commercially available segmentation algorithms that
are well-documented and user-friendly for CNV analyses
and provide visualization of the results in a biological
context. While our evaluation indicators such as NSR
and ROC curve residuals were promising for the Nexus
methods, there are concerns about these methods. Rank’s
ROC residuals were inflated by the abundant number of
calls as reflected in simulation 2 with a false positive rate
of 44% at the CNV level and in the analysis dataset with
the lowest specificity of all methods. Rank also has
boundary calling problems, with most CNVs called 1–2
SNPs too long and 3–4 SNP CNVs called as 6–7 SNP
CNVs. Both Nexus methods have difficulty achieving
sufficient power at moderate false positive rates. For
example, in simulation 2 and the neutral and Affymetrix
simulations, SNPRank can only achieve moderate power
while Rank only has high power with a high false
positive rate.
The correlation between the results at the CNV and
CNV SNP levels are influenced by the boundary calling
properties of the method and by the statistical properties
of the specificity calculation at the two levels. For
example, in simulation 1, QuantiSNP’s inaccuracies in
boundary calling give a moderately high-false positive
rate at the CNV SNP level, while at the CNV level there
are zero false positives. This is one factor contributing to
QuantiSNP’s different optimal parameters for the two
levels. The second factor is the specificity calculation.
For example, because a single false positive CNV has
more impact than a single false positive CNV SNP on
both false positive rate and sensitivity, Rank’s overabun-
dant CNV calls made the optimal parameter for CNV
SNPs (1E–3) less stringent than the one for CNVs (1E–4).
Is there an inherent advantage for QuantiSNP, because
it was developed for Illumina SNP arrays, while CBS,
GLAD and CNVFinder were developed for other plat-
forms? A definite answer cannot be given here, because
testing on real data from multiple platforms was not
done here. QuantiSNP could have this advantage, but
there are other possibilities. One possibility is that
methods developed for SNP array data, like HMMs, are
more sophisticated than the methods developed for other
platforms, like segmentation and SD-based methods,
which would indicate that the advantage of QuantiSNP
is method based instead of platform based. Another pos-
sibility is that the inherent quality of QuantiSNP, regard-
less of platform or method type, is higher than that of
other methods. There is evidence that the latter is true.
First, CBS ranks higher than PennCNV in the analysis,
simulation 2, Affymetrix simulation and neutral simula-
tion datasets. This shows that not all HMM methods
are superior to segmentation methods like CBS and
Nexus. Furthermore, this shows that methods not
developed for SNP arrays can outperform methods
created for SNP arrays. Second, CBS both has good per-
formance in this SNP array study, and it also had the best
performance in the Lai et al. 2005 (10) CGH study, giving
additional evidence for platform-independent ranking
performance.
The PennCNV program is a HMM-based algorithm
like the QuantiSNP program and is probably the most
frequently used program for CNV studies in recent publi-
cations (14–16). This is in part due to the user-friendly
design of the program and free access to users.
However, our evaluation ranked the performance of
PennCNV at the intermediate level. Simulation 2 showed
that the PennCNV program has moderate power.
However, its low false positive rate is a promising
aspect. The NSR and ROC curve residuals were
moderate on real data. It generally detects less CNVs
than other methods except cnvPartition in the analysis
dataset. It also has some trouble detecting small CNVs
(three to four SNP CNVs), which is exacerbated by
using stricter than optimal parameters used in our study.
These observations serve as good references for the appli-
cation of PennCNV.
In tuning parameters, the NSR is a more straightfor-
ward measure than using ROC curves. It is database inde-
pendent and does not require the calculation of multiple
statistics. As a database independent measure, the NSR
does not have to take into account CNV database issues
such as limited CNV studies in certain populations, largely
unknown CNV population frequencies, and the fact that
studies without dense marker spacing call a higher number
of CNVs relative to real CNV counts. For instance, we
found very low sensitivity between our population and the
corresponding ethnic population in the Database of
Genomic Variants (3). This is largely due to the large
number of CNVs and the lack of CNV validation in
DGV. The NSR is robust to the tested Illumina SNP
array platforms, to gender bias, and to genotyping
quality levels, since it was minimal at the same parameters
on multiple values of these characteristics of the training
dataset. Our study showed that the same conclusion can
be drawn based on NSR and ROC curve residuals, which
validates the usage of the NSR. In comparing method
quality, the NSR overcomes the correlation between the
number of CNV calls and sensitivity, specificity and
kappa, which allows every method to be set at any param-
eter setting.
Since datasets vary in their logR ratio SDs, B allele
frequency distributions and other factors, there is no
single parameter setting for all datasets. Therefore, the
determination of parameter setting for a CNV detection
method can be a challenge. Without a priori knowledge,
one may choose the default setting of the program, which
may not be optimal. In this study, we proposed to stan-
dardize the parameters in a small subset of samples before
the full analysis. Since half of the methods tested take at
least 15 minutes per sample, it is important to find a
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technique that requires an initial few samples to test
multiple parameter settings in order to find the optimal
parameters. On the other hand, this strategy should be
able to ensure that the optimal parameter setting deter-
mined in the training dataset is also optimal for the full
dataset. The method used in this study accomplishes both
goals. In our real data example, 10 training samples were
sufficient to find the same optimal parameters as those
found for the analysis dataset of 100 samples. As a sec-
ondary confirmation of optimal parameters on a training
dataset, the ROC curve residual can be used with the NSR
to determine if the two metrics agree. Overall, the NSR
and the ROC curve residuals can provide good guidance
for tuning parameters to the optimal level.
Although blood-derived DNA is considered the best
choice for genotyping, not all studies can obtain blood
samples, particularly for studies involving child subjects.
Our analysis of DNA types on the pilot dataset concluded
that buccal, saliva and blood DNA samples were compa-
rable in CNV detection thus, these DNA sources are
adequate for CNV detection. However, this conclusion
may be limited to this set of small pilot samples that
were selected because of known high genotype call rates.
The only DNA type that showed poor performance for
CNV detection by all methods was the amplified buccal
DNA, as has been seen in previous studies (17,18). All
methods detected too many CNV SNPs in the amplified
buccal DNA compared to other DNA types (10 times as
many), even though genotype call rates were still above
98%. Therefore, amplified buccal DNA was determined to
be unreliable for CNV detection, possibly due to the large
variation in the logR distribution of these samples (data
not shown).
This comparison is limited in that: more parameters
could be tested, especially less conservative parameters
than were found to be optimal; marker density of the
one million marker array will provide more accurate
CNV detection and may alter relative outcomes among
the methods; and there are many new methods not
tested in this study. However, many more parameters
were run than are shown here, and optimal parameters
were often the least conservative parameter available to
the method. Also, increased marker density is not likely to
change the core characteristics of the methods found in
this study or to radically change the rankings of the
methods tested. For example, weakness in detecting
CNVs with few SNPs and in boundary calling conditions
should not change with an increase in marker density.
Finally, this study can be used as a template for easy
future studies of the many new CNV detection methods
that are available now and in the future.
In summary, the utility of determining CNVs from SNP
arrays usually occurs in two steps: (i) determine the
genome location, and number and size of the CNVs and
(ii) relate these CNVs with phenotypes of interest using
methods such as association analyses. The detection of
CNVs plays an important role in the final conclusion of
the study. Among the seven methods evaluated in this
report, we conclude that the QuantiSNP program
outperformed the other methods. We also presented the
limitations of each method in terms of failure of CNV
detection. The NSR can be used as a valid evaluation
parameter of method quality in CNV detection methods.
Use of the NSR and a training dataset as demonstrated
herein serves as a valid template for determining optimal
parameter setting for the method of choice prior to the full
data analysis.
Web resources
Database of Genomic Variants, http://projects.tcag
.ca/variation/.
Online Mendelian Inheritance in Man (OMIM),
http://www.ncbi.nlm.nih.gov/Omim/.
Redon databases, http://www.nature.com/nature/
journal/v444/n7118/full/nature05329.html.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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